[go: up one dir, main page]

PT1169026E - Utilizacao de activadores de ap-1 no tratamento do glaucoma e da hipertensao ocular - Google Patents

Utilizacao de activadores de ap-1 no tratamento do glaucoma e da hipertensao ocular

Info

Publication number
PT1169026E
PT1169026E PT00921979T PT00921979T PT1169026E PT 1169026 E PT1169026 E PT 1169026E PT 00921979 T PT00921979 T PT 00921979T PT 00921979 T PT00921979 T PT 00921979T PT 1169026 E PT1169026 E PT 1169026E
Authority
PT
Portugal
Prior art keywords
activators
glaucoma
treatment
eye hypertension
hypertension
Prior art date
Application number
PT00921979T
Other languages
English (en)
Inventor
Debra L Shade
Iok-Hou Pang
Abbot F Clark
Original Assignee
Alcon Mfg Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alcon Mfg Ltd filed Critical Alcon Mfg Ltd
Publication of PT1169026E publication Critical patent/PT1169026E/pt

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
    • A61K31/05—Phenols
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline 
    • A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0048—Eye, e.g. artificial tears
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/02—Ophthalmic agents
    • A61P27/06—Antiglaucoma agents or miotics

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Ophthalmology & Optometry (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Medicinal Preparation (AREA)
PT00921979T 1999-04-20 2000-04-07 Utilizacao de activadores de ap-1 no tratamento do glaucoma e da hipertensao ocular PT1169026E (pt)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US13013399P 1999-04-20 1999-04-20

Publications (1)

Publication Number Publication Date
PT1169026E true PT1169026E (pt) 2004-10-29

Family

ID=22443214

Family Applications (1)

Application Number Title Priority Date Filing Date
PT00921979T PT1169026E (pt) 1999-04-20 2000-04-07 Utilizacao de activadores de ap-1 no tratamento do glaucoma e da hipertensao ocular

Country Status (12)

Country Link
EP (1) EP1169026B1 (pt)
JP (1) JP2002542189A (pt)
AT (1) ATE270883T1 (pt)
AU (1) AU766199B2 (pt)
BR (1) BR0009862A (pt)
CA (1) CA2369126A1 (pt)
DE (1) DE60012163T2 (pt)
DK (1) DK1169026T3 (pt)
ES (1) ES2223502T3 (pt)
HK (1) HK1039568B (pt)
PT (1) PT1169026E (pt)
WO (1) WO2000062769A2 (pt)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US8603964B2 (en) 2008-07-04 2013-12-10 Institut National De La Sante Et De La Recherche Medicale (Inserm) Methods for modulating angiogenesis via dystrophin Dp71

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5981568A (en) * 1993-01-28 1999-11-09 Neorx Corporation Therapeutic inhibitor of vascular smooth muscle cells
CN1169857A (zh) * 1996-07-10 1998-01-14 林东和 降眼压活性组合物

Also Published As

Publication number Publication date
WO2000062769A2 (en) 2000-10-26
DK1169026T3 (da) 2004-10-04
ES2223502T3 (es) 2005-03-01
DE60012163D1 (de) 2004-08-19
WO2000062769A3 (en) 2001-01-04
HK1039568A1 (en) 2002-05-03
EP1169026B1 (en) 2004-07-14
JP2002542189A (ja) 2002-12-10
CA2369126A1 (en) 2000-10-26
AU766199B2 (en) 2003-10-09
DE60012163T2 (de) 2004-11-11
HK1039568B (en) 2004-12-10
EP1169026A2 (en) 2002-01-09
AU4223100A (en) 2000-11-02
ATE270883T1 (de) 2004-07-15
BR0009862A (pt) 2002-01-08

Similar Documents

Publication Publication Date Title
DE69521620D1 (de) Verwendung von 9-deoxyprostaglandinderivaten zur behandlung von glaukom
DK1039912T3 (da) Angiostatiske midler og præparater til behandling af GLC1A-glaukom
ATE426413T1 (de) Verfahren und zusammensetzungen zur behandlung von okularer neovaskularisierung und nervenverletzungen
DE60023043T2 (de) (S,S)-Reboxetin zur Behandlung von Inkontinenz
TR200002773T2 (tr) Alzheimer tedavisi için smilagenin ve anzurogenin-D ve bunların kullanımı.
ATE254461T1 (de) Behandlung von augenschmerzen
BR0210241A (pt) Piranoindazóis e seu uso no tratamento de glaucoma
WO2000038663A3 (en) Ep4 receptor agonists for treatment of dry eye
PT1246835E (pt) Sapogeninas substituídas e sua utilização
CY1106409T1 (el) Παραγωγα κινολινης
DE60008143D1 (de) Lipoxin-a4 und deren analoge zur behandlung von trockenen augen
GB2402674B (en) Compositions and methods for the treatment of glaucoma or ocular hypertension
MXPA02004701A (es) Sales de hidroxieicosatetraenoato, composiciones y metodos de uso para tratar trastornos de resequedad en los ojos.
DE69705421D1 (de) 15-fluoro-prostaglandine als augendrucksenkende mittel
WO1998020880A3 (en) 11-Halo prostaglandins for the treatment of glaucoma or ocular hypertension
WO1998039293A3 (en) 13-thia prostaglandins for use in glaucoma therapy
BR0017163A (pt) Derivados 5-hidróxi-indazol para tratamento do glaucoma
MXPA03003741A (es) Metodos y composiciones para el tratamiento de enfermedades oftalmicas.
TR200101149T2 (tr) Dış retina bozukluklarının tedavisi.
GB9923078D0 (en) Sapogenin derivatives and their use
ATE258793T1 (de) 5-ht2 agonisten als mittel zur kontrolle des augeninnendrucks und zur behandlung von glaukom
TR200200278T2 (tr) Kalsilitik bileşimler
PT1169026E (pt) Utilizacao de activadores de ap-1 no tratamento do glaucoma e da hipertensao ocular
ATE291425T1 (de) R-eliprodil zur behandlung von glaucoma
ZA200302911B (en) Method and composition for treatment of ocular hypertension and glaucoma.